Compound information
- Natural Products
- ZC802750
- Molecular Formula
- C17H20N4O
- Molecular Weight
- 296.16371126 g/mol
- Structure
-
- IUPAC Name
- 4-benzyl-N-(3-pyridyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C17H20N4O/c22-17(19-16-7-4-8-18-13-16)21-11-9-20(10-12-21)14-15-5-2-1-3-6-15/h1-8,13H,9-12,14H2,(H,19,22)
- InChI Key
- AZXHTFWEBMZPRT-UHFFFAOYSA-N
- SMILES
- O=C(Nc1cccnc1)N1CCN(Cc2ccccc2)CC1
- Source
- ZINC000023652893
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 3 |
Heteroatom Count | 5 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 48.47 Å2 | LogP | 1.755 |
LogS | -2.321 | LogD | 2.26 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.109 | Pgp substrate | 0.799 |
HIA | 0.903 | F20 % | 0.969 |
F30 % | 0.762 | Caco-2 | -4.816 |
MDCK | -5.047 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.556 | PPB | 53.218 |
VD | 1.075 | Fu | 0.631 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.072 | CYP1A2 substrate | 0.718 |
CYP2A6 substrate | 0.834 | CYP2B6 substrate | 0.77 |
CYP2C19 inhibitor | 0.672 | CYP2C19 substrate | 0.719 |
CYP2C8 substrate | 0.744 | CYP2C9 inhibitor | 0.756 |
CYP2C9 substrate | 0.314 | CYP2D6 inhibitor | 0.922 |
CYP2D6 substrate | 0.995 | CYP2E1 substrate | 0.891 |
CYP3A4 inhibitor | 0.059 | CYP3A4 substrate | 0.971 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.842 | CL | 12.065 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.344 | Hepatotoxicity | 0.324 |
Mutagenicity | 0.0 | Rat Oral Acute Toxicity | 0.803 |
FDAMDD | 0.343 | Skin Sensitization | 0.978 |
Carcinogenicity | 0.029 | Eye Corrosion | 0.002 |
Eye Irritation | 0.009 | Respiratory Toxicity | 0.957 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.259 | IGC50 | 3.146 |
LC50FM | 1.906 | LC50DM | -3.065 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.373 | NR-AR-LBD | 0.19 |
NR-AhR | 0.656 | NR-Aromatase | 0.02 |
NR-ER | 0.348 | NR-ER-LBD | 0.293 |
NR-PPAR-gamma | 0.16 | SR-ARE | 0.797 |
SR-ATAD5 | 0.371 | SR-HSE | 0.153 |
SR-MMP | 0.015 | SR-p53 | 0.04 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.